Evidence map›Paper›PMID 32019600›Full record

ReviewCritical care (London, England)2020

Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.

Laurence W Busse, Nicholas Barker, Christopher Petersen

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Critical care (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 81 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 3 pooled it
17.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06539234 recruitingnot on this mapstarted 2024, after this paper: background citation

Angiotensin II Stress Test. Renin Kinetics During Treatment of Vasoplegic Shock With Angiotensin II in Relation to Hemodynamic Response to Treatment With Angiotensin II.

TypeobservationalSponsorUniversity Medical Centre MariborRan2024 to 2026Enrolled80ConditionsShock, Vasoplegic Syndrome
NCT07671365 phase4not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Angiotensin II for Post Cardiac Surgery Vasoplegia (ANGII_V)

TypeinterventionalSponsorMethodist Healthcare System of San AntonioRan2026 to 2030Enrolled329ConditionsVasoplegic Shock, Cardiopulmonary Bypass, VasoplegiaArmsAngiotensin II (Giapreza®)
3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 3 syntheses or guidelines pooled it, 206 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Observational
  9. Review
  10. Observational
  11. The effect of intravenous calcium administration on haemodynamics in perioperative cardiothoracic surgery and intensive care: A narrative review.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Laurence W BusseDepartment of Medicine, Emory University, Emory Critical Care Center, Atlanta, GA, USA. lbusse@emory.edu.ORCID http://orcid.org/0000-0002-6564-5200
Nicholas BarkerDepartment of Pharmacy, Emory St. Joseph's Hospital, Atlanta, GA, USA.
Christopher PetersenDepartment of Pharmacy, Stanford Health Care, Palo Alto, California, USA.
Emory University · USSaint Joseph's Hospital · USStanford Health Care · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vasoplegic syndrome is a common occurrence following cardiothoracic surgery and is characterized as a high-output shock state with poor systemic vascular resistance. The pathophysiology is complex and includes dysregulation of vasodilatory and vasoconstrictive properties of smooth vascular muscle cells. Specific bypass machine and patient factors play key roles in occurrence. Research into treatment of this syndrome is limited and extrapolated primarily from that pertaining to septic shock, but is evolving with the expanded use of catecholamine-sparing agents. Recent reports demonstrate potential benefit in novel treatment options, but large clinical trials are needed to confirm.

Indexed as

Adrenal Cortex HormonesAngiotensin IIAscorbic AcidCardiac Surgical ProceduresDopamineEnzyme InhibitorsEpinephrineHumansMethylene BlueNorepinephrinePhenylephrineSympathomimeticsVascular ResistanceVasoconstrictor AgentsVasoplegiaVasopressinsAdrenal Cortex HormonesAngiotensin IIAscorbic AcidDopamineEnzyme InhibitorsEpinephrineMethylene BlueNorepinephrinePhenylephrineSympathomimeticsVasoconstrictor AgentsVasopressinsAngiotensin IICardiopulmonary bypassDe-catecholaminizationHydroxocobalaminShockVasoplegic syndrome

Identifiers

PMID32019600
PMCPMC7001322
OpenAlexW3006211703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.